Shopping Cart 0
Cart Subtotal
AED 0

Pharmaceuticals in Japan

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 3854
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Pharmaceuticals in Japan

 

Summary

 

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Japanese pharmaceuticals market had total revenues of USD 70.9m in 2018, representing a compound annual growth rate (CAGR) of 2% between 2014 and 2018.

- The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.3% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 79.4m by the end of 2023.

- Japans healthcare system is undergoing sweeping reform to mitigate the rising healthcare costs of its ageing population.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the Japan pharmaceuticals market by value in 2018?

- What will be the size of the Japan pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the Japan pharmaceuticals market?

- How has the market performed over the last five years?

- How large is Japan's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Astellas Pharma Inc.

Daiichi Sankyo Co Ltd

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Company Limited

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Japan pharmaceuticals market value: USD billion, 2014-18

Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: Japan pharmaceuticals market share: % share, by value, 2018

Figure 4: Japan pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in Japan, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in Japan, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in Japan, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2018

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: Daiichi Sankyo Co Ltd: revenues & profitability

Figure 14: Daiichi Sankyo Co Ltd: assets & liabilities

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities


List Of Table

List of Tables

Table 1: Japan pharmaceuticals market value: USD billion, 2014-18

Table 2: Japan pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: Japan pharmaceuticals market share: % share, by value, 2018

Table 4: Japan pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials (USD )

Table 7: Astellas Pharma Inc.: key financials (JPY)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: Daiichi Sankyo Co Ltd: key facts

Table 10: Daiichi Sankyo Co Ltd: key financials (USD )

Table 11: Daiichi Sankyo Co Ltd: key financials (JPY)

Table 12: Daiichi Sankyo Co Ltd: key financial ratios

Table 13: Mitsubishi Tanabe Pharma Corporation: key facts

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (USD )

Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (JPY)

Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios

Table 17: Takeda Pharmaceutical Company Limited: key facts

Table 18: Takeda Pharmaceutical Company Limited: key financials (USD )

Table 19: Takeda Pharmaceutical Company Limited: key financials (JPY)

Table 20: Takeda Pharmaceutical Company Limited: key financial ratios

Table 21: Japan size of population (million), 2014-18

Table 22: Japan gdp (constant 2005 prices, USD billion), 2014-18

Table 23: Japan gdp (current prices, USD billion), 2014-18

Table 24: Japan inflation, 2014-18

Table 25: Japan consumer price index (absolute), 2014-18

Table 26: Japan exchange rate, 2014-18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Astellas Pharma Inc.

Daiichi Sankyo Co Ltd

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Company Limited

Pharmaceuticals in Japan

 

Summary

 

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Japanese pharmaceuticals market had total revenues of USD 70.9m in 2018, representing a compound annual growth rate (CAGR) of 2% between 2014 and 2018.

- The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.3% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 79.4m by the end of 2023.

- Japans healthcare system is undergoing sweeping reform to mitigate the rising healthcare costs of its ageing population.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the Japan pharmaceuticals market by value in 2018?

- What will be the size of the Japan pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the Japan pharmaceuticals market?

- How has the market performed over the last five years?

- How large is Japan's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Astellas Pharma Inc.

Daiichi Sankyo Co Ltd

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Company Limited

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Japan pharmaceuticals market value: USD billion, 2014-18

Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: Japan pharmaceuticals market share: % share, by value, 2018

Figure 4: Japan pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in Japan, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in Japan, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in Japan, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2018

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: Daiichi Sankyo Co Ltd: revenues & profitability

Figure 14: Daiichi Sankyo Co Ltd: assets & liabilities

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities


List Of Table

List of Tables

Table 1: Japan pharmaceuticals market value: USD billion, 2014-18

Table 2: Japan pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: Japan pharmaceuticals market share: % share, by value, 2018

Table 4: Japan pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials (USD )

Table 7: Astellas Pharma Inc.: key financials (JPY)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: Daiichi Sankyo Co Ltd: key facts

Table 10: Daiichi Sankyo Co Ltd: key financials (USD )

Table 11: Daiichi Sankyo Co Ltd: key financials (JPY)

Table 12: Daiichi Sankyo Co Ltd: key financial ratios

Table 13: Mitsubishi Tanabe Pharma Corporation: key facts

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (USD )

Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (JPY)

Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios

Table 17: Takeda Pharmaceutical Company Limited: key facts

Table 18: Takeda Pharmaceutical Company Limited: key financials (USD )

Table 19: Takeda Pharmaceutical Company Limited: key financials (JPY)

Table 20: Takeda Pharmaceutical Company Limited: key financial ratios

Table 21: Japan size of population (million), 2014-18

Table 22: Japan gdp (constant 2005 prices, USD billion), 2014-18

Table 23: Japan gdp (current prices, USD billion), 2014-18

Table 24: Japan inflation, 2014-18

Table 25: Japan consumer price index (absolute), 2014-18

Table 26: Japan exchange rate, 2014-18

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Astellas Pharma Inc.

Daiichi Sankyo Co Ltd

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Company Limited